Lord, Abbett & Co’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-332,597
| Closed | -$10.6M | – | 597 |
|
|
2023
Q2 | $10.6M | Sell |
332,597
-305
| -0.1% | -$9.7K | 0.04% | 413 |
|
|
2023
Q1 | $8.12M | Sell |
332,902
-788,664
| -70% | -$19.2M | 0.03% | 428 |
|
|
2022
Q4 | $35.4M | Buy |
1,121,566
+35,610
| +3% | +$1.12M | 0.13% | 235 |
|
|
2022
Q3 | $30.7M | Buy |
1,085,956
+82,992
| +8% | +$2.35M | 0.11% | 245 |
|
|
2022
Q2 | $26.5M | Buy |
1,002,964
+273,114
| +37% | +$7.22M | 0.09% | 286 |
|
|
2022
Q1 | $25.6M | Buy |
729,850
+685
| +0.1% | +$24K | 0.07% | 340 |
|
|
2021
Q4 | $23.6M | Buy |
+729,165
| New | +$23.6M | 0.05% | 374 |
|